Refractory CMV infection in post-transplant phase: epidemiological framing in the Italian context, current patient management and unmet needs
Background: Cytomegalovirus (CMV) infection usually occurs asymptomatically but can represent an important cause of morbidity and mortality in patients with compromised immune system such as transplant patients. Infection may not respond to standard therapies leading to refractoriness (with or witho...
Main Authors: | Marianna Morani, Fausto Baldanti, Fabio Ciceri, Franco Citterio, Mariano Ferraresso, Corrado Girmenia, Umberto Maggiore, Massimo Martino, Francesco Onida, Luciano Potena, Fabio Vistoli, Paolo Antonio Grossi |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2023-06-01
|
Series: | AboutOpen |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/2564 |
Similar Items
-
Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation
by: Ian Pang, et al.
Published: (2022-01-01) -
Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
by: Restelli U, et al.
Published: (2019-05-01) -
CMV hyperimmune globulin as salvage therapy for recurrent or refractory CMV infection in children undergoing hematopoietic stem cell transplantation
by: Melissa Panesso, et al.
Published: (2023-07-01) -
Cytomegalovirus infection in transplant recipients
by: Luiz Sergio Azevedo, et al.
Published: (2015-07-01) -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?
by: Fabian Herrera
Published: (2024-04-01)